Commenting on the introduction of Genio in Amsterdam, Dr. Peter van Maanen, ENT surgeon at OLVG West, stated: “Dr. Mayke ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University's College ...

Apyron, Inc. is a medical technology company with a product portfolio designed to address chronic pain and joint-related disorders, with a core value to restore mobility in patients and provide them ...

Mainstay Medical Holdings plc today announced that the International Society for the Advancement of Spine Surgery (ISASS) has issued recommendations and coverage criteria for the use of restorative ...

One of the most common causes of epilepsy is a structural brain abnormality. “Epilepsy can result from structural issues in ...

OverviewThe global neurotech devices market is experiencing strong momentum and is projected to grow at a CAGR of approximately 13% over the forecast period. This growth trajectory is shaped by ...

SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...

Explore eight groundbreaking inventions transforming health and well-being, from NeoRhythm’s advanced neurostimulation for fatigue relief to Dexcom G7’s real-time glucose monitoring. Discover ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. The latest update is out from Nyxoah ( (NYXH) ).

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience.  | The FDA issued a green light that covers the ...